Poongjeon Pharmacy CO.,LTD. (KOSDAQ:298060)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,635.00
+95.00 (2.09%)
At close: Apr 22, 2026
-6.74%
Market Cap 40.98B
Revenue (ttm) 1.54B
Net Income (ttm) -8.24B
Shares Out 8.84M
EPS (ttm) -362.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 61,080
Average Volume 28,192
Open 4,610.00
Previous Close 4,540.00
Day's Range 4,475.00 - 4,795.00
52-Week Range 3,750.00 - 8,375.00
Beta 0.75
RSI 66.34
Earnings Date n/a

About KOSDAQ:298060

POONGJEON PHARMACY CO.,LTD. operates as a stem cell therapy company in South Korea. It develops SCM-AGH, a treatment for moderate to severe acute pancreatitis and moderate to severe atopic dermatitis, as well as chronic graft versus host disease; and Iroro Deerscalp, a toothbrush cosmetic for hair loss relief. The company was formerly known as SCM Lifescience Co., Ltd. and change its name to POONGJEON PHARMACY CO.,LTD. in April 2026. The company was incorporated in 2014 and is headquartered in Incheon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 298060
Full Company Profile

Financial Performance

In 2024, KOSDAQ:298060's revenue was 824.80 million, an increase of 18.56% compared to the previous year's 695.70 million. Losses were -12.38 billion, -48.35% less than in 2023.

Financial Statements

News

There is no news available yet.